Changing the world together…
We want to create a world where people can live longer… a world where the best minds continue doing their best work… a world where we can spend more time with our loved ones.
What we do?
From the point of our inception, we recognised technology’s vast potential for change. This drove us to begin work on our first mobile application, and the rest is history. Since those early days in 2011, we have expanded across every facet of digital health, transforming how healthcare providers, doctors and patients connect with each other in the process. Our remote patient monitoring applications, mobile technology and advanced data analytics unite to deliver a highly personalised, efficient care experience. Headquartered in London, CE approved and we are proud of the prestigious organisations that use our solutions every day. Clients include numerous NHS trusts, HCA, Bayer, national healthcare providers, global pharmaceutical organisations, insurance providers, governments, charities, sporting clubs and brands, and countless others.
What our users say about us
Ena CrawforthOncology Patient
At first I thought, will I be able to use this new technology, as I’m not familiar with it. But It’s made me feel a lot more confident, and I feel very calm about it and pleased with it.
Stefanie WerhahnClinical Team Gottingen
The information from Medopad on my patients enables me to better treat and understand them. In the future, this data may even help to detect signs of disease worsening at a stage where hospitalisation can be prevented and to monitor patients at high risk even more closely. The doctors platform is well designed and clearly structured; patient information can be quickly grasped and the regular checks are a nice addition to everyday clinical practice.
Séan MatheikenConsultant Vascular Surgeon
Medopad has enabled the successful implementation of a secure mobile tool for remote clinical image capture and retrieval across the Royal Free London NHS Foundation Trust. I value the partnership forged with Medopad and intend to cement this over ongoing and future projects.